Annual CFO
-$117.98 M
-$8.90 M-8.16%
31 December 2023
Summary:
Tango Therapeutics annual cash flow from operations is currently -$117.98 million, with the most recent change of -$8.90 million (-8.16%) on 31 December 2023. During the last 3 years, it has fallen by -$188.06 million (-268.37%). TNGX annual CFO is now -268.37% below its all-time high of $70.07 million, reached on 31 December 2020.TNGX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$33.39 M
-$9.78 M-41.44%
30 September 2024
Summary:
Tango Therapeutics quarterly cash flow from operations is currently -$33.39 million, with the most recent change of -$9.78 million (-41.44%) on 30 September 2024. Over the past year, it has dropped by -$2.25 million (-7.24%). TNGX quarterly CFO is now -344.13% below its all-time high of -$7.52 million, reached on 30 June 2021.TNGX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$122.32 M
-$2.25 M-1.88%
30 September 2024
Summary:
Tango Therapeutics TTM cash flow from operations is currently -$122.32 million, with the most recent change of -$2.25 million (-1.88%) on 30 September 2024. Over the past year, it has dropped by -$3.54 million (-2.98%). TNGX TTM CFO is now -798.56% below its all-time high of -$13.61 million, reached on 31 March 2021.TNGX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNGX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.2% | -7.2% | -3.0% |
| 3 y3 years | -268.4% | -55.4% | -187.0% |
| 5 y5 years | - | - | - |
TNGX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -268.4% | at low | -97.5% | +11.8% | -187.0% | at low |
| 5 y | 5 years | -268.4% | at low | -344.1% | +11.8% | -798.6% | at low |
| alltime | all time | -268.4% | at low | -344.1% | +11.8% | -798.6% | at low |
Tango Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$33.39 M(+41.4%) | -$122.32 M(+1.9%) |
| June 2024 | - | -$23.61 M(-37.6%) | -$120.07 M(-0.7%) |
| Mar 2024 | - | -$37.86 M(+37.8%) | -$120.93 M(+2.5%) |
| Dec 2023 | -$117.98 M(+8.2%) | -$27.47 M(-11.8%) | -$117.98 M(-0.7%) |
| Sept 2023 | - | -$31.14 M(+27.2%) | -$118.78 M(+10.7%) |
| June 2023 | - | -$24.47 M(-29.9%) | -$107.26 M(-6.2%) |
| Mar 2023 | - | -$34.91 M(+23.5%) | -$114.32 M(+4.8%) |
| Dec 2022 | -$109.08 M | -$28.27 M(+44.1%) | -$109.08 M(+11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$19.61 M(-37.8%) | -$97.72 M(-1.9%) |
| June 2022 | - | -$31.54 M(+6.3%) | -$99.60 M(+31.8%) |
| Mar 2022 | - | -$29.66 M(+75.5%) | -$75.58 M(+27.0%) |
| Dec 2021 | -$59.53 M(-184.9%) | -$16.90 M(-21.4%) | -$59.53 M(+39.7%) |
| Sept 2021 | - | -$21.49 M(+185.9%) | -$42.63 M(+101.7%) |
| June 2021 | - | -$7.52 M(-44.8%) | -$21.13 M(+55.2%) |
| Mar 2021 | - | -$13.61 M | -$13.61 M |
| Dec 2020 | $70.07 M | - | - |
FAQ
- What is Tango Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Tango Therapeutics?
- What is Tango Therapeutics annual CFO year-on-year change?
- What is Tango Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Tango Therapeutics?
- What is Tango Therapeutics quarterly CFO year-on-year change?
- What is Tango Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Tango Therapeutics?
- What is Tango Therapeutics TTM CFO year-on-year change?
What is Tango Therapeutics annual cash flow from operations?
The current annual CFO of TNGX is -$117.98 M
What is the all time high annual CFO for Tango Therapeutics?
Tango Therapeutics all-time high annual cash flow from operations is $70.07 M
What is Tango Therapeutics annual CFO year-on-year change?
Over the past year, TNGX annual cash flow from operations has changed by -$8.90 M (-8.16%)
What is Tango Therapeutics quarterly cash flow from operations?
The current quarterly CFO of TNGX is -$33.39 M
What is the all time high quarterly CFO for Tango Therapeutics?
Tango Therapeutics all-time high quarterly cash flow from operations is -$7.52 M
What is Tango Therapeutics quarterly CFO year-on-year change?
Over the past year, TNGX quarterly cash flow from operations has changed by -$2.25 M (-7.24%)
What is Tango Therapeutics TTM cash flow from operations?
The current TTM CFO of TNGX is -$122.32 M
What is the all time high TTM CFO for Tango Therapeutics?
Tango Therapeutics all-time high TTM cash flow from operations is -$13.61 M
What is Tango Therapeutics TTM CFO year-on-year change?
Over the past year, TNGX TTM cash flow from operations has changed by -$3.54 M (-2.98%)